Early Academic Pursuits
His journey into the realm of pharmaceutical research began with a strong foundation in chemistry. Graduating with honors in Chemistry, Physics, and Mathematics from the University of Burdwan, India, he exhibited exceptional academic prowess. His passion for organic chemistry led him to pursue a Master's degree with a specialization in Organic Chemistry from the University of Calcutta. Subsequently, he delved deeper into the field by obtaining his Ph.D. in Biochemistry from CSIR-Indian Institute of Chemical Biology/University of Calcutta. During his academic pursuits, he developed a keen interest in natural product chemistry, cancer chemoprevention, and translational research.
Professional Endeavors
His professional journey in pharmaceutical research spans over a decade, during which he has made significant contributions to the field. His post-doctoral experience at CSIR-Indian Institute of Chemical Biology and the University of Pittsburgh provided him with invaluable exposure to natural product research, cancer chemoprevention, and translational studies. Subsequently, he continued his research endeavors as a Scientist at IASST, Guwahati, where he focused on metabolic disorders and translational research. His expertise and dedication earned him recognition as a Senior Research Associate and Senior Research Fellow under the prestigious Scientist Pool's Scheme and CSIR, respectively.
Contributions and Research Focus in Drug Development
His research focuses on chemoprevention, molecular pharmacology, signal cross-talk, system biology, and translational research. His notable contributions include elucidating the mechanisms of action of natural compounds like Ajoene and Withaferin A in breast cancer treatment. Through rigorous in vitro and in vivo studies, he demonstrated the efficacy of Withaferin A in inhibiting breast cancer progression, irrespective of the cancer subtype. Additionally, his research shed light on the role of PIN1 protein in breast cancer progression and the inhibitory effects of Withaferin A on PIN1, offering novel therapeutic avenues for cancer treatment. Currently, he is exploring the therapeutic potential of combining the dietary phytochemical Mahanine with conventional medications for breast cancer treatment, further advancing the field of translational research.
Accolades and Recognition
His outstanding contributions to pharmaceutical research have earned him several accolades and awards. His notable achievements include being awarded as a Senior Research Associate and Senior Research Fellow by CSIR. Additionally, his research findings have been published in prestigious journals like the Journal of the National Cancer Institute, garnering recognition and acclaim from the scientific community.
Impact and Influence
His therapeutic targets, he has contributed significantly to the field of medicinal chemistry and pharmacology. His findings have the potential to revolutionize cancer treatment strategies and improve patient outcomes worldwide.
Legacy and Future Contributions